High Court Denies Bid To Review Neurontin RICO Rulings
The U.S. Supreme Court on Monday denied Pfizer Inc.'s bid to rehear three First Circuit rulings related to its allegedly deceptive marketing of Neurontin, allowing to stand the First Circuit's determination...To view the full article, register now.
Already a subscriber? Click here to view full article